Search results for "analytical"

Article How the Industrial Internet of Things is Transforming Bioprocessing
In this article, Jun Huang, director and team leader of Process Monitoring, Automation, and Control at Pfizer, discusses the impact of digitalization in biomanufacturing. He also discusses ho…

Article 2019 HTPD Conference is Approaching. What Happened Last Time?
The 5th international conference devoted to high-throughput process development (HTPD) and smart PD will take place on November 4­–7, 2019 in Porto, Portugal. HTPD 2019 will cover process develo…

Article 2019 HTPD Conference Abstract Submissions Are Coming Up: What Happened Last Time?
The 5th international conference devoted to high-throughput process development (HTPD) and smart PD, will take place November 4–7, 2019 in Porto, Portugal.    HTPD 2019 will cover process…

Article Optimized Process Efficiency in Upstream Manufacturing
Process efficiency is a key goal for biopharmaceutical production. Click here to learn how faster cell-line development, real-time analytics, and other approaches can be used to create a flexi…

Article Addressing the Complex Nature of Downstream Processing with QbD
We have also developed many high-throughput tools applicable to process and product development within upstream, downstream formulations, and analytical development,” MacDonald says. The benefits …

Article 2019 HTPD Conference Is Announced. What Happened Last Time?
The 5th international conference devoted to high-throughput process development (HTPD) and smart PD, will take place November 4-7, 2019 in Porto, Portugal.   HTPD 2019 will cover process devel…

Article Selectivity in Size Exclusion Chromatography (SEC): It’s Much More than Average Pore Diameter (Å)
Describing the pore of a size exclusion chromatography resin with a single number such as average pore diameter is an oversimplification. The formation of pores is dependent on complex combinations of…

Article Webinar On Demand: Expanding SPR Uses in Antibody Effector Function Determination
Critical quality attributes (CQAs) are fundamental to regulatory compliance. CQAs typically include data on how the candidate interacts with target proteins, as well as process-related CQAs such as pr…

Article Leveraging Computational Models of Glycosylation for Biopharma QA
Close collaboration between academic and industrial groups is vital to ensuring glycosylation models are fit for deployment. By Ioscani Jiménez del Val Good Studio/S…

Article Are You in Control of the Quality of Your mAbs?
Better biotherapeutic characterization for improved quality control At the recent WCBP conference in Washington, D.C., Dr. Stuart Knowling from Antibody Analytics presented how the latest innovati…

Previous PageNext Page